Peri-Implantitis as a Self-Accelerating Process: A Critical Review of Microbial, Immune, and Mechanically Generated Drivers and a Cohort Protocol to Test Titanium-Particle Amplification of Dysbiotic Inflammation
- Paper type
- Mechanistic critical review with an embedded prospective biomarker cohort protocol
- Status
- Original Work · Working Paper
- Keywords:
- peri-implantitis · peri-implant mucositis · dysbiosis · titanium particles · inflammasome · disease progression · submucosal microbiome · occlusal overload
Contents
- 1Introduction and Clinical Significance
- 2Critical Review of the Established Literature
- 3Identification of the Specific Research Gap
- 4Scientific Objective and Hypotheses
- 5Theoretical Foundation: A Coupled Model of Progression
- 6Methodology
- 7Evidence Synthesis and Explicitly Labeled Theoretical Predictions
- 8Discussion: Mechanisms and Competing Explanations
- 9Implications for Implant Surgery and Restorative Dentistry
- 10Technical and Clinical Limitations
- 11Proposed Experimental and Clinical Validation
- 12Future Research Directions
- 13Evidence-Calibrated Conclusion
Abstract
Background: Peri-implantitis is a plaque-associated inflammatory condition with progressive loss of supporting bone. Its lesions are larger and more neutrophil- and plasma-cell-rich than periodontitis lesions, and its progression in untreated patients is non-linear and accelerating. Cross-sectional studies associate the disease with dysbiotic submucosal communities and with elevated titanium in peri-implant tissues and biofilm, but the direction of these associations is unresolved.
Objective: To review the mechanisms that initiate and propagate peri-implantitis, to propose a model in which microbial, immune, and mechanically generated factors are coupled, and to design a study able to refute it.
Methods: Critical narrative review prioritizing consensus reports, systematic reviews, human biopsy studies, and controlled animal experiments. A feedback model was formulated in which bone loss enlarges the anaerobic niche and exposes implant surface, and a power-law progression equation was derived for empirical testing. A prospective inception cohort of implants with peri-implant mucositis was specified.
Findings: Evidence that biofilm initiates mucosal inflammation is strong and experimental. Evidence that mechanical overload causes marginal bone loss in the absence of inflammation is weak, while animal data indicate that overload aggravates plaque-induced bone loss. Evidence that titanium particles contribute is associative in humans and mechanistic in vitro. We hypothesize that progression follows a power law with exponent greater than one and that titanium load at baseline modifies the hazard of progression conditional on dysbiosis. A hazard ratio whose confidence interval includes one after adjustment would refute the second claim; a progression exponent indistinguishable from one would refute the first.
Conclusions: Peri-implantitis is best understood as an infection-driven inflammatory disease whose rate, and possibly whose threshold, is modified by host and implant-derived factors. Whether titanium debris is a cause, a consequence, or a bystander can be settled only by longitudinal measurement that begins before bone is lost.
Keywords: peri-implantitis; peri-implant mucositis; dysbiosis; titanium particles; inflammasome; disease progression; submucosal microbiome; occlusal overload
1. Introduction and Clinical Significance
Peri-implant diseases were defined by the 2017 World Workshop as plaque-associated conditions: peri-implant mucositis, an inflammatory lesion confined to the mucosa, and peri-implantitis, in which inflammation is accompanied by progressive loss of supporting bone [1]. A systematic review of the epidemiology estimated weighted mean prevalences of 43 percent for mucositis and 22 percent for peri-implantitis at the patient level, with wide ranges that depended heavily on the case definition applied [2]. In a randomly selected Swedish population examined nine years after therapy, 45 percent of patients had peri-implantitis when a bone-loss threshold of more than 0.5 mm was used and 14.5 percent had moderate to severe disease with bone loss exceeding 2 mm [3]. A later meta-analysis reported pooled estimates of roughly one patient in five and one implant in eight [4]. The dependence of prevalence on definition is a long-recognized weakness of the clinical literature [5], and it has a biological implication that is easy to miss: the disease is being counted at different points along a trajectory whose shape is itself part of the pathology.
That trajectory is unusual. In the Swedish cohort, radiographic analysis of affected implants showed that bone loss began early, within the first three years of function in most cases, and proceeded in a non-linear, accelerating pattern [6]. The consensus report adopted this description [1]. Periodontitis, by comparison, is ordinarily slow. A disease that accelerates has a mechanism that feeds on its own result, and identifying that mechanism is the central problem addressed here.
The clinical stakes are considerable. Non-surgical treatment of established peri-implantitis is unreliable, surgical treatment is demanding, and current guidance places its emphasis on prevention and on the management of mucositis [7, 8]. Prevention is only as good as the understanding of what converts a reversible mucosal lesion into a destructive one. Three families of explanation compete: the microbial, the immunological, and the mechanical or material. This paper argues that they are not alternatives, examines the quality of evidence for each, and proposes a way to test their coupling.
2. Critical Review of the Established Literature
Biofilm as the initiating agent
The causal role of plaque in mucosal inflammation is established by human experiment. When oral hygiene was withdrawn, clinical inflammation developed around implants as around teeth [9], and in a later experimental study the inflammatory response to the same period of plaque accumulation was more pronounced at implants; three weeks of reinstituted plaque control reversed the changes only partly at the clinical level [10]. In patients with mucositis who received no preventive maintenance, the five-year incidence of peri-implantitis was markedly higher than in those who were maintained [11], and a meta-analysis found that maintenance therapy reduced the occurrence of peri-implant disease [12]. The World Workshop review of mucositis accordingly identified it as the precursor of peri-implantitis and plaque as its etiological factor [13].
The lesion
Peri-implantitis lesions differ from periodontitis lesions in extent and composition. Human biopsy studies described large inflammatory infiltrates extending apical of the pocket epithelium, with abundant plasma cells, lymphocytes, neutrophils, and macrophages [14], and a direct comparison found that peri-implantitis lesions were more than twice the size of periodontitis lesions and contained greater densities of plasma cells, macrophages, and neutrophil granulocytes [15]. A review of the comparative histopathology concluded that the absence of a connective tissue capsule separating the infiltrate from bone is a consistent feature [16]. The experimental correlate was described three decades ago: ligature-induced lesions at implants in the dog extended into the bone marrow, whereas lesions at teeth remained separated from bone by intact connective tissue [17]. When ligatures were removed and plaque allowed to accumulate, spontaneous progression was greater at implants than at teeth and more pronounced at implants with a modified surface [18]. Naturally occurring human defects and ligature-induced canine defects share a circumferential morphology [19], and in patients the bone loss tends to involve the full circumference of affected implants [20].
The structural explanation usually offered is anatomical. The peri-implant mucosa lacks a periodontal ligament and inserting Sharpey's fibers; its collagen runs parallel to the implant surface; and the supracrestal tissue is less vascular than gingiva [21]. A lesion that breaches the junctional epithelium meets no fiber barrier and no cementum, and lies directly against bone.
The microbial community
Culture-independent studies changed the description of the peri-implant microbiota. Sequencing showed that communities around healthy and diseased implants differ from each other and from subgingival communities in the same mouths [22], and that adjacent teeth and implants in the same individual share only a minority of their bacterial lineages [23]. The peri-implant sulcus is therefore a distinct habitat and not a simple extension of the periodontal one. Disease is associated with a shift in community structure toward anaerobic, proteolytic, inflammophilic taxa, consistent with the general model of polymicrobial synergy and dysbiosis in which inflammation supplies the nutrients on which the pathogenic community depends [24, 25]. Reviews of peri-implant microbial etiology emphasize that the peri-implantitis community is heterogeneous between patients and that no single organism is necessary [26]; others argue that the implant material itself shapes the community and that the disease should not be regarded as periodontitis around a different substrate [27].
What sequencing studies cannot establish, being almost entirely cross-sectional, is whether dysbiosis precedes bone loss or follows the creation of a deep, anaerobic, rough-walled pocket.
Titanium release and the material hypothesis
Titanium is detectable in peri-implant tissues, and more of it is found around diseased implants. Metal elements were identified in soft-tissue and bone biopsies from peri-implantitis sites together with M1-polarized macrophages [28]; dissolved titanium was higher in submucosal plaque from implants with peri-implantitis than from healthy implants [29]; and titanium quantity in plaque was associated with peri-implantitis status and with the composition of the microbiome [30]. A systematic review confirmed that particles and ions are released from dental implants through insertion wear, corrosion, friction at the implant-abutment interface, and instrumentation, while noting that a causal relation with biological complications was unproven [31]. Mechanistically, titanium ions formed particles in culture medium that activated the release of interleukin-1β from lipopolysaccharide-primed macrophages, an inflammasome-dependent response that requires both a microbial priming signal and a particulate activation signal [32].
The interpretation is disputed. One position holds that metal particle release is an emerging contributor to peri-implant bone destruction that deserves systematic study [33]. A critical review concluded that there was no evidence that titanium particles or biocorrosion initiate peri-implantitis and that the associations may reflect corrosion and wear produced by the inflammatory, acidic environment and by treatment [34]. A related line of argument regards marginal bone loss as the consequence of a disturbed foreign-body equilibrium in which infection is a late and secondary event [35]; the consensus report rejected that position on the evidence available, maintaining that peri-implantitis is plaque-associated [1, 36].
Mechanical factors
Occlusal overload has been proposed as a cause of marginal bone loss since the earliest clinical series. The experimental evidence is narrow. Loss of osseointegration followed heavy supra-occlusal lateral loading in a monkey model [37], but excessive occlusal load in the dog, applied with plaque control, did not cause bone loss [38]. In a dog experiment that crossed loading with inflammation, overloading increased bone-to-implant contact when the mucosa was healthy and aggravated bone resorption when plaque-induced inflammation was present [39]. A systematic review concluded that the effect of overload on bone or implant loss around well-integrated implants is poorly reported and that little unbiased evidence supports a cause-and-effect relationship [40]. The 2017 consensus found no evidence that occlusal overload is a risk factor for the onset or progression of peri-implantitis in humans [1].
Mechanical factors reach the tissues by other routes as well. Prosthesis contours that impede access for cleaning are associated with disease: a convex profile with a wide emergence angle was a risk indicator for peri-implantitis around bone-level implants [41]. Residual luting cement was associated with clinical and endoscopic signs of peri-implant disease, which resolved in most cases after its removal [42]. Both act through plaque retention and local irritation and not through stress in bone.
Host susceptibility
A history of periodontitis, poor plaque control, and lack of maintenance are the best-supported risk indicators [36, 43]. A meta-analysis found a higher risk of peri-implantitis in people with diabetes or hyperglycemia than in normoglycemic individuals, independent of smoking [44]. Evidence for smoking as an independent indicator was judged inconclusive by the consensus. Host-derived markers in crevicular fluid, including interleukin-1β and matrix metalloproteinase-8, are elevated at diseased sites [45, 46], though none has been validated as a predictor of progression.
3. Identification of the Specific Research Gap
Established facts are these. Plaque accumulation causes mucositis. Peri-implantitis lesions are large, poorly encapsulated, and rich in neutrophils and plasma cells. Progression is non-linear. Diseased sites harbor dysbiotic communities and elevated titanium. Overload aggravates plaque-induced bone loss in animals.
The uncertainty concerns coupling and sequence. Does the microbial community change before or after bone loss begins? Is titanium a cause of inflammation, a product of it, or both? Why do some mucositis lesions persist for years without bone loss while others convert? A recent overview of the field by its leading investigators identifies the transition from mucositis to peri-implantitis and the reasons for the rapid progression as unresolved [47].
Existing methods cannot answer these questions for three reasons. First, the dominant design is the cross-sectional comparison of healthy and diseased implants, which cannot order events in time. Second, exposures are measured after the outcome: titanium in a pocket that has been inflamed, acidic, and possibly instrumented for years says nothing about titanium before the disease. Third, outcome definitions vary, and recommended outcome measures have only recently been standardized [48]. A fourth limitation is statistical. Because disease clusters within patients, implant-level analyses that ignore clustering overstate precision.
The specific gap is the absence of an inception cohort in which microbial composition, inflammatory mediators, and titanium load are measured at implants that have mucositis but intact bone, and then related to the subsequent rate of bone loss.
4. Scientific Objective and Hypotheses
The objective is to determine whether progression from peri-implant mucositis to peri-implantitis is governed by positive feedback between bone loss and the dysbiotic inflammatory burden, and whether implant-derived titanium modifies that process.
Hypothesis H3a (acceleration). In implants that develop peri-implantitis, marginal bone loss B over time follows a power law with exponent α greater than 1 (Equation 1). H3a is falsified if, in longitudinal radiographic data with at least four time points per implant, the 95% credible interval for α includes 1 or lies below it.
Hypothesis H3b (amplification). Among implants with mucositis at baseline, a higher titanium concentration in submucosal biofilm is associated with a higher hazard of incident peri-implantitis, and the association is stronger at implants with a high baseline dysbiosis index. H3b is falsified if the hazard ratio per doubling of titanium concentration has a 95% confidence interval that includes 1 after adjustment for plaque score, history of periodontitis, diabetes, smoking, and maintenance compliance, and if the interaction with dysbiosis is likewise indistinguishable from null.
Hypothesis H3c (sequence). The dysbiosis index rises after, and in proportion to, the first detectable bone loss, in addition to any baseline difference. H3c is falsified if within-implant change in dysbiosis is unrelated to preceding bone-level change.
The hypotheses are separable. H3a could hold while H3b fails, which would indicate feedback without a material contribution. H3b could fail while cross-sectional titanium associations persist, which would favor reverse causation.
5. Theoretical Foundation: A Coupled Model of Progression
Phenomenological form
Let B(t) be marginal bone loss in millimeters beyond the level established after initial remodeling. A general description of self-dependent progression is
dB/dt = r B^α (1)
where r is a rate coefficient with units that depend on α and α is a dimensionless exponent. For α = 0 the rate is constant and loss is linear in time. For α = 1 loss is exponential. For α greater than 1 the solution with initial value B0 is
B(t) = [B_0^1-α - (α - 1) r t]^((-1)/(α-1)) (2)
which rises ever more steeply and is bounded in practice only by the length of the implant. The exponent is estimable from serial radiographs and distinguishes three biological situations: a constant insult (α near 0), a process proportional to its own extent (α near 1), and a process in which each increment of loss increases the per-unit rate (α above 1).
Mechanistic sketch
The power law is a summary. A mechanistic account that would generate it has three state variables: bone loss B, the dysbiotic microbial load M in the pocket, and the inflammatory burden I in the adjacent connective tissue. We write
dM/dt = ρ M (1 - M/(K_0 + s B)) (3)
I = g M (1 + κ T) (4)
dB/dt = c (I - I_0) for I > I_0 (5)
Equation 3 is logistic growth of the dysbiotic community with intrinsic rate ρ toward a carrying capacity that increases with pocket depth; K0 is the capacity of a shallow sulcus and s the gain in anaerobic, nutrient-rich niche per millimeter of bone loss. Equation 4 states that inflammatory burden is proportional to microbial load with gain g and is amplified by local titanium load T with coefficient κ. The multiplicative form encodes the two-signal requirement observed in vitro, where particles provoked interleukin-1β release only from macrophages primed by a microbial stimulus [32]: titanium without biofilm yields no burden, and biofilm without titanium yields the baseline response. Equation 5 states that bone is resorbed at a rate proportional to the excess of inflammatory burden over a host-specific tolerance I0, with coefficient c.
The loop closes because bone loss raises carrying capacity, which raises microbial load, which raises inflammation, which causes bone loss. Two further links, both plausible and neither quantified, would steepen it: exposure of microrough implant surface increases the area for biofilm retention, and corrosion and wear in an inflamed crevice may raise T [31, 34]. If T is itself an increasing function of I, titanium becomes part of the feedback and not an external modifier, and the distinction between cause and consequence dissolves into a question about rates.
What the model implies
Several familiar observations follow. A threshold I0 accounts for mucositis that persists without bone loss: inflammation is present but below the level at which resorption outpaces repair. Host factors such as hyperglycemia or a history of periodontitis can be represented as a lower I0 or a higher g. Maintenance lowers M directly. Overload does not appear as an initiating term, in keeping with the lack of unbiased evidence for a causal effect [40]; it can be represented as an increase in c, the bone's resorptive response per unit of inflammation, which reproduces the finding that load aggravated bone loss only in inflamed sites [39]. The larger, unencapsulated lesion at implants [15] corresponds to a higher g and a lower I0 than at teeth.
The model's parameters are not known. Its purpose is to state the hypotheses in a form that longitudinal data can contradict.
6. Methodology
Review methods
The review is narrative and critical. Priority was given to the 2017 World Workshop consensus and its commissioned reviews, to systematic reviews, to human biopsy studies, and to controlled animal experiments. Each mechanistic claim is labeled by evidence type in Table 1. No formal risk-of-bias tool was applied; a systematic review restricted to longitudinal studies with exposure measured before disease onset would be a logical next step and should follow PRISMA 2020.
Cohort design
The proposed study is a prospective inception cohort reported according to STROBE [49]. The unit of enrollment is the patient; the unit of observation is the implant. Eligible implants have been in function for at least one year, show bleeding on gentle probing, and have no bone loss beyond initial remodeling as judged against a baseline radiograph, satisfying the workshop definition of mucositis [1, 13]. Up to two implants per patient are enrolled to limit clustering. All participants receive standard professional maintenance, since withholding it would be unethical; the cohort therefore studies progression despite maintenance, which is the clinically relevant situation.
Exposures and biomarkers
At baseline and every six months, the following are collected at each study implant before any instrumentation. Submucosal biofilm is sampled with sterile paper points or curettes made of a non-titanium material, to avoid contaminating the titanium assay. One aliquot is used for 16S rRNA gene sequencing, from which a dysbiosis index is computed as the log ratio of the summed relative abundance of taxa previously associated with disease to that of taxa associated with health, with the taxon lists fixed in advance from published datasets [22, 23]. A second aliquot is digested and analyzed by inductively coupled plasma mass spectrometry for titanium, normalized to sample mass [29]. Peri-implant crevicular fluid is collected on strips for interleukin-1β and matrix metalloproteinase-8 [45]. Field blanks and instrument blanks are processed with every batch, because environmental titanium, including pigment in consumables, is a recognized source of contamination.
Mechanical and prosthetic covariates are recorded: connection type, retention mode, emergence angle and profile on radiographs [41], presence of occlusal wear facets, and bruxism by structured assessment. These are included as covariates and potential effect modifiers; the study is not designed to estimate occlusal load.
Outcomes
The primary outcome is incident peri-implantitis according to the 2017 definition: bleeding or suppuration on probing with increased probing depth and radiographic bone loss beyond the measurement error relative to baseline [1]. Bone level is measured on standardized periapical radiographs with individualized holders at baseline and annually, by two calibrated examiners blind to exposure data. For implants that reach the primary outcome, additional radiographs at six-month intervals for two years, where clinically justified, provide the series needed to estimate α. Outcome reporting follows recently recommended measures [48].
| Claim | Best available evidence | Main weakness |
|---|---|---|
| Plaque accumulation causes mucositis [9, 10] | Human experimental studies | Short duration; small samples |
| Mucositis without maintenance progresses to peri-implantitis [11, 12] | Cohort studies; meta-analysis | Non-randomized; confounding by compliance |
| Lesions are larger and less encapsulated than in periodontitis [14, 15, 17] | Human biopsies; animal experiments | Biopsies from advanced disease only |
| Progression is non-linear and accelerating [6] | Retrospective radiographic analysis | Irregular radiograph timing; one population |
| Dysbiosis is associated with disease [22, 26] | Cross-sectional sequencing | Temporal order unknown |
| Titanium is elevated at diseased sites [28–30] | Cross-sectional human studies | Reverse causation; contamination risk |
| Titanium particles activate the inflammasome in primed macrophages [32] | In vitro | Dose and form may not reflect in vivo exposure |
| Overload aggravates plaque-induced bone loss [39] | Animal experiment | Supraphysiological loads; no human confirmation |
Statistical analysis
H3b is tested with a Cox model for time to peri-implantitis with a shared frailty term for patient. Baseline log-transformed titanium concentration, the dysbiosis index, and their product are the exposures of interest; adjustment covariates are listed in Section 4. To use the repeated biomarker measurements, a joint model links a longitudinal sub-model for each marker to the hazard:
h_i(t) = h_0(t) exp(γ^T w_i + η m_i(t)) (6)
where hi(t) is the hazard for implant i, h0(t) the baseline hazard, wi the vector of baseline covariates with coefficients γ, mi(t) the current underlying value of the biomarker from the longitudinal sub-model, and η the association parameter. H3c is examined with cross-lagged models relating change in dysbiosis index to preceding change in bone level and the reverse. H3a is tested by fitting Equation 1 to the bone-level series of progressing implants in a Bayesian hierarchical model with implant-specific r and a population-level α.
Sample size
The number of incident cases determines power. If one in five implants with mucositis under maintenance converts within five years, a figure adopted for planning from the range reported in maintained cohorts [11] and subject to revision, 500 implants in about 300 patients would yield approximately 100 events before attrition. With 100 events, a hazard ratio of 1.5 per standard deviation of a continuous exposure is detectable with power above 0.9 at two-sided α of 0.05, by the standard approximation for Cox regression; detecting an interaction of the same magnitude requires roughly four times as many events and would be underpowered. The interaction test in H3b should therefore be regarded as exploratory unless the cohort is extended.
7. Evidence Synthesis and Explicitly Labeled Theoretical Predictions
Synthesis
Weighing the evidence in Table 1, the initiating role of biofilm is the only link supported by human experimental data. The anatomical vulnerability of the peri-implant attachment is supported by consistent histology. The accelerating course rests on one large radiographic study, credible but unreplicated. The dysbiosis and titanium links are associative. The overload link is experimental but animal-only and conditional on inflammation.
Theoretical predictions
The following are deductions from Section 5 and have not been tested.
Prediction 1. If α exceeds 1, the time to lose each successive millimeter of bone shortens. Early bone loss of small magnitude is therefore a stronger warning than its size suggests, and case definitions with high bone-loss thresholds will systematically detect disease late in its course.
Prediction 2. Under the multiplicative form of Equation 4, titanium load will show no association with progression at implants with a low dysbiosis index and a positive association at implants with a high index. An additive effect of titanium independent of dysbiosis would contradict the two-signal premise.
Prediction 3. If titanium elevation is purely a consequence of inflammation, baseline titanium at mucositis sites will not predict conversion, but titanium will rise after conversion. If it is a contributor, baseline titanium will predict conversion. If both, baseline titanium will predict and will also rise. The cohort distinguishes these three patterns.
Prediction 4. The dysbiosis index will increase with pocket deepening within implants over time, reflecting the dependence of carrying capacity on B in Equation 3.
Prediction 5. Prosthetic contours that impede cleaning will act through M, and their effect on hazard will be attenuated after adjustment for plaque score and dysbiosis index; a residual direct effect would point to an unmodeled pathway.
8. Discussion: Mechanisms and Competing Explanations
The model is deliberately conservative about initiation and speculative about acceleration. It accepts the consensus that plaque initiates disease [1, 36] and asks what makes the disease, once begun, proceed faster at implants than at teeth.
The anatomical explanation needs no new entities. Without a ligament, cementum, or inserting fibers, there is less tissue to contain a lesion, and the infiltrate reaches bone sooner [16, 17]. On this account α may exceed 1 simply because a deeper pocket holds more biofilm, and titanium is irrelevant. H3a would be supported and H3b refuted. That outcome would be a clear and useful result.
The material explanation adds the implant as a participant. Its strongest support is mechanistic: a particulate second signal for inflammasome activation in cells already primed by bacterial products [32]. Its weakness is the difficulty of showing that particle concentrations at human implants reach biologically active levels before disease. The association of titanium with microbiome structure [30] can be read in either direction: titanium may select for certain taxa, or a corrosive dysbiotic biofilm may release titanium. Critics are right that no existing human study excludes the second reading [34]. The proposed cohort does not presume the first; it measures titanium before bone loss and lets the data assign the order.
The foreign-body explanation holds that bone loss is primarily an immune reaction to the implant in which bacteria are secondary [35]. The model can represent this as a low tolerance I0 that varies between hosts and materials, but it would predict bone loss in the absence of dysbiosis, which the experimental mucositis and maintenance literature does not support. A cohort finding of frequent progression at sites with low plaque and low dysbiosis index would revive it.
The overload explanation has the least human support, and the consensus position is that it is not an established risk factor [1]. It retains interest because of the animal finding that load and inflammation interact [39]. If overload increases the resorptive response to a given inflammatory burden, it would appear in a cohort as an interaction between a load proxy and inflammatory markers, and not as a main effect. The present design can look for such a signal but cannot quantify load; that limitation is acknowledged, and a dedicated study with measured occlusal force would be required to pursue it.
Measurement issues qualify all of these. Probing at implants is influenced by prosthesis contour and soft-tissue dimensions; radiographs show only mesial and distal bone; sequencing gives relative, not absolute, abundance, so that an index based on ratios can change without any change in the pathogenic load. Absolute quantification by quantitative polymerase chain reaction of total bacterial load should accompany sequencing. The titanium assay does not distinguish ionic from particulate forms, nor implant-derived metal from titanium dioxide of dietary or dentifrice origin; particle characterization by electron microscopy on a subsample would help.
The functional forms chosen in Section 5 are open to challenge, and the alternatives are informative. If titanium acted additively, as an independent irritant, Equation 4 would read as a sum, and the cohort would show an association between titanium and progression at implants with little dysbiosis; the multiplicative form forbids that. If the carrying capacity of the pocket saturated with depth, the feedback would weaken as disease advanced and the fitted exponent would fall toward or below 1 in late disease even if it exceeded 1 early; the hierarchical model should therefore allow the exponent to differ between early and late segments of each series. If host tolerance were not a fixed threshold but declined with cumulative exposure, as might occur with trained or exhausted innate responses, conversion would depend on the duration of mucositis as well as on its intensity, and duration of bleeding on probing before enrollment, where records allow it to be estimated, becomes a covariate of interest. None of these variants can be distinguished from the others with cross-sectional data, and each makes a different longitudinal prediction, which is the principal argument for the design proposed here.
The practical meaning of an accelerating disease deserves emphasis independent of mechanism. Under a power law with exponent above 1, delay is disproportionately costly. A diagnostic threshold of 2 mm of bone loss, convenient for epidemiology, may sit on the steep part of the curve.
9. Implications for Implant Surgery and Restorative Dentistry
Current evidence supports management directed at biofilm: prostheses designed for access, avoidance of residual cement, enrollment in maintenance, and prompt treatment of mucositis [7, 8]. Nothing in this review alters that priority. The accelerating pattern of progression argues for baseline radiographs at prosthesis delivery and for acting on small, confirmed changes instead of waiting for a conventional threshold.
The titanium hypothesis has practical corollaries that are reasonable on other grounds and cost little: avoiding unnecessary abrasion of implant surfaces during maintenance, and preferring instruments and protocols that minimize surface damage. Implantoplasty and aggressive mechanical debridement generate particles; whether that matters biologically is unknown, and the present review does not justify abandoning procedures with clinical evidence of benefit.
For restorative dentists, emergence profile and cleansability are the mechanical factors with the best human evidence [41, 42]. Occlusal adjustment as a treatment for peri-implantitis lacks support; control of inflammation comes first.
10. Technical and Clinical Limitations
The review is narrative and may be incomplete. The model is a sketch with unmeasured parameters and several arbitrary functional forms; other formulations would generate similar curves. The dysbiosis index depends on predefined taxon lists derived from populations that may not generalize. The cohort cannot randomize exposure, so residual confounding, for instance by unmeasured host inflammatory phenotype, remains possible. All participants receive maintenance, which will reduce event frequency and limit generalization to unmaintained patients. Radiographic bone-level measurement has an error of several tenths of a millimeter, comparable to early annual changes, which limits the precision with which α can be estimated. Finally, the two-implant limit per patient reduces but does not eliminate clustering, and patient-level susceptibility may dominate implant-level exposures.
11. Proposed Experimental and Clinical Validation
Three complementary studies would test the framework. The first is the inception cohort described above. The second is a secondary analysis of existing radiographic series from untreated peri-implantitis, where they exist, fitting Equation 1 to estimate α and replicate or refute the reported acceleration [6]; this requires no new patients and could be done first. The third is experimental. In an established canine model, peri-implantitis would be induced by ligature and plaque with or without local application of characterized titanium particles at doses bracketing those measured in human sites, crossed with plaque control, in a 2 by 2 design [18]. The two-signal hypothesis predicts an effect of particles only in the plaque-accumulation arms. Such a study requires ethical review and adherence to animal-research reporting standards and should be undertaken only if the cohort or pre-existing human data give reason to pursue it.
Each hypothesis has a stated refutation: α not greater than 1; an adjusted hazard ratio for titanium whose interval includes 1; no temporal relation between bone change and subsequent dysbiosis.
12. Future Research Directions
If acceleration is confirmed, the practical question becomes how early the inflection can be detected, which points toward serial low-dose imaging or validated crevicular-fluid markers of bone resorption. If titanium amplification is supported, materials research on wear- and corrosion-resistant transmucosal components gains a biological rationale; if it is refuted, that effort can be redirected. Single-cell and spatial transcriptomic study of the peri-implantitis lesion could test whether inflammasome activation co-localizes with particles. Host genetics and the systemic inflammatory state remain underexplored modifiers of the tolerance term. Mechanical loading as a modifier of inflammatory bone loss in humans is an open question that will need direct load measurement.
13. Evidence-Calibrated Conclusion
That biofilm initiates peri-implant mucosal inflammation is supported by human experimental evidence and is not in serious doubt. That peri-implantitis lesions are larger and less contained than periodontitis lesions is supported by consistent human and animal histology. That progression accelerates is supported by a single large retrospective study and needs replication. That dysbiosis and titanium release contribute to progression, as opposed to resulting from it, is unproven. That occlusal overload contributes in humans is unsupported at present. The coupled model proposed here unifies these observations as a feedback process, yields a measurable exponent and a testable interaction, and specifies the inception-cohort design required to establish temporal order. Its claims are hypotheses, and clinical practice should continue to rest on biofilm control and supportive care.
Cite this paper
Jain S, Gupta A. Peri-Implantitis as a Self-Accelerating Process: A Critical Review of Microbial, Immune, and Mechanically Generated Drivers and a Cohort Protocol to Test Titanium-Particle Amplification of Dysbiotic Inflammation. Working paper. Center for Implant Dentistry; 2026. Available from: https://bayareaimplantdentistry.com/clinician-research-and-publications/coupled-drivers-of-peri-implantitis-progression
References
- Berglundh T, Armitage G, Araujo MG, Avila-Ortiz G, Blanco J, Camargo PM, et al. Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89 Suppl 1:S313-S318. doi:10.1002/JPER.17-0739 (opens in a new tab) PMID: 29926955 (opens in a new tab).
- Derks J, Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol. 2015;42 Suppl 16:S158-71. doi:10.1111/jcpe.12334 (opens in a new tab) PMID: 25495683 (opens in a new tab).
- Derks J, Schaller D, Håkansson J, Wennström JL, Tomasi C, Berglundh T. Effectiveness of Implant Therapy Analyzed in a Swedish Population: Prevalence of Peri-implantitis. J Dent Res. 2016;95(1):43-9. doi:10.1177/0022034515608832 (opens in a new tab) PMID: 26701919 (opens in a new tab).
- Diaz P, Gonzalo E, Villagra LJG, Miegimolle B, Suarez MJ. What is the prevalence of peri-implantitis? A systematic review and meta-analysis. BMC Oral Health. 2022;22(1):449. doi:10.1186/s12903-022-02493-8 (opens in a new tab) PMID: 36261829 (opens in a new tab).
- Tomasi C, Derks J. Clinical research of peri-implant diseases--quality of reporting, case definitions and methods to study incidence, prevalence and risk factors of peri-implant diseases. J Clin Periodontol. 2012;39 Suppl 12:207-23. doi:10.1111/j.1600-051X.2011.01831.x (opens in a new tab) PMID: 22533958 (opens in a new tab).
- Derks J, Schaller D, Håkansson J, Wennström JL, Tomasi C, Berglundh T. Peri-implantitis - onset and pattern of progression. J Clin Periodontol. 2016;43(4):383-8. doi:10.1111/jcpe.12535 (opens in a new tab) PMID: 26900869 (opens in a new tab).
- Jepsen S, Berglundh T, Genco R, Aass AM, Demirel K, Derks J, et al. Primary prevention of peri-implantitis: managing peri-implant mucositis. J Clin Periodontol. 2015;42 Suppl 16:S152-7. doi:10.1111/jcpe.12369 (opens in a new tab) PMID: 25626479 (opens in a new tab).
- Herrera D, Berglundh T, Schwarz F, Chapple I, Jepsen S, Sculean A, et al. Prevention and treatment of peri-implant diseases-The EFP S3 level clinical practice guideline. J Clin Periodontol. 2023;50 Suppl 26:4-76. doi:10.1111/jcpe.13823 (opens in a new tab) PMID: 37271498 (opens in a new tab).
- Pontoriero R, Tonelli MP, Carnevale G, Mombelli A, Nyman SR, Lang NP. Experimentally induced peri-implant mucositis. A clinical study in humans. Clin Oral Implants Res. 1994;5(4):254-9. doi:10.1034/j.1600-0501.1994.050409.x (opens in a new tab) PMID: 7640340 (opens in a new tab).
- Salvi GE, Aglietta M, Eick S, Sculean A, Lang NP, Ramseier CA. Reversibility of experimental peri-implant mucositis compared with experimental gingivitis in humans. Clin Oral Implants Res. 2012;23(2):182-190. doi:10.1111/j.1600-0501.2011.02220.x (opens in a new tab) PMID: 21806683 (opens in a new tab).
- Costa FO, Takenaka-Martinez S, Cota LO, Ferreira SD, Silva GL, Costa JE. Peri-implant disease in subjects with and without preventive maintenance: a 5-year follow-up. J Clin Periodontol. 2012;39(2):173-81. doi:10.1111/j.1600-051X.2011.01819.x (opens in a new tab) PMID: 22111654 (opens in a new tab).
- Monje A, Aranda L, Diaz KT, Alarcón MA, Bagramian RA, Wang HL, et al. Impact of Maintenance Therapy for the Prevention of Peri-implant Diseases: A Systematic Review and Meta-analysis. J Dent Res. 2016;95(4):372-9. doi:10.1177/0022034515622432 (opens in a new tab) PMID: 26701350 (opens in a new tab).
- Heitz-Mayfield LJA, Salvi GE. Peri-implant mucositis. J Periodontol. 2018;89 Suppl 1:S257-S266. doi:10.1002/JPER.16-0488 (opens in a new tab) PMID: 29926954 (opens in a new tab).
- Berglundh T, Gislason O, Lekholm U, Sennerby L, Lindhe J. Histopathological observations of human periimplantitis lesions. J Clin Periodontol. 2004;31(5):341-7. doi:10.1111/j.1600-051X.2004.00486.x (opens in a new tab) PMID: 15086615 (opens in a new tab).
- Carcuac O, Berglundh T. Composition of human peri-implantitis and periodontitis lesions. J Dent Res. 2014;93(11):1083-8. doi:10.1177/0022034514551754 (opens in a new tab) PMID: 25261052 (opens in a new tab).
- Berglundh T, Zitzmann NU, Donati M. Are peri-implantitis lesions different from periodontitis lesions? J Clin Periodontol. 2011;38 Suppl 11:188-202. doi:10.1111/j.1600-051X.2010.01672.x (opens in a new tab) PMID: 21323715 (opens in a new tab).
- Lindhe J, Berglundh T, Ericsson I, Liljenberg B, Marinello C. Experimental breakdown of peri-implant and periodontal tissues. A study in the beagle dog. Clin Oral Implants Res. 1992;3(1):9-16. doi:10.1034/j.1600-0501.1992.030102.x (opens in a new tab) PMID: 1420727 (opens in a new tab).
- Carcuac O, Abrahamsson I, Albouy JP, Linder E, Larsson L, Berglundh T. Experimental periodontitis and peri-implantitis in dogs. Clin Oral Implants Res. 2013;24(4):363-71. doi:10.1111/clr.12067 (opens in a new tab) PMID: 23176551 (opens in a new tab).
- Schwarz F, Herten M, Sager M, Bieling K, Sculean A, Becker J. Comparison of naturally occurring and ligature-induced peri-implantitis bone defects in humans and dogs. Clin Oral Implants Res. 2007;18(2):161-70. doi:10.1111/j.1600-0501.2006.01320.x (opens in a new tab) PMID: 17348880 (opens in a new tab).
- Fransson C, Tomasi C, Pikner SS, Gröndahl K, Wennström JL, Leyland AH, et al. Severity and pattern of peri-implantitis-associated bone loss. J Clin Periodontol. 2010;37(5):442-8. doi:10.1111/j.1600-051X.2010.01537.x (opens in a new tab) PMID: 20507368 (opens in a new tab).
- Ivanovski S, Lee R. Comparison of peri-implant and periodontal marginal soft tissues in health and disease. Periodontol 2000. 2018;76(1):116-130. doi:10.1111/prd.12150 (opens in a new tab) PMID: 29193334 (opens in a new tab).
- Kumar PS, Mason MR, Brooker MR, O'Brien K. Pyrosequencing reveals unique microbial signatures associated with healthy and failing dental implants. J Clin Periodontol. 2012;39(5):425-33. doi:10.1111/j.1600-051X.2012.01856.x (opens in a new tab) PMID: 22417294 (opens in a new tab).
- Dabdoub SM, Tsigarida AA, Kumar PS. Patient-specific analysis of periodontal and peri-implant microbiomes. J Dent Res. 2013;92(12 Suppl):168S-75S. doi:10.1177/0022034513504950 (opens in a new tab) PMID: 24158341 (opens in a new tab).
- Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol. 2012;10(10):717-25. doi:10.1038/nrmicro2873 (opens in a new tab) PMID: 22941505 (opens in a new tab).
- Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018;16(12):745-759. doi:10.1038/s41579-018-0089-x (opens in a new tab) PMID: 30301974 (opens in a new tab).
- Belibasakis GN, Manoil D. Microbial Community-Driven Etiopathogenesis of Peri-Implantitis. J Dent Res. 2021;100(1):21-28. doi:10.1177/0022034520949851 (opens in a new tab) PMID: 32783779 (opens in a new tab).
- Kotsakis GA, Olmedo DG. Peri-implantitis is not periodontitis: Scientific discoveries shed light on microbiome-biomaterial interactions that may determine disease phenotype. Periodontol 2000. 2021;86(1):231-240. doi:10.1111/prd.12372 (opens in a new tab) PMID: 33690947 (opens in a new tab).
- Fretwurst T, Buzanich G, Nahles S, Woelber JP, Riesemeier H, Nelson K. Metal elements in tissue with dental peri-implantitis: a pilot study. Clin Oral Implants Res. 2016;27(9):1178-86. doi:10.1111/clr.12718 (opens in a new tab) PMID: 26508041 (opens in a new tab).
- Safioti LM, Kotsakis GA, Pozhitkov AE, Chung WO, Daubert DM. Increased Levels of Dissolved Titanium Are Associated With Peri-Implantitis - A Cross-Sectional Study. J Periodontol. 2017;88(5):436-442. doi:10.1902/jop.2016.160524 (opens in a new tab) PMID: 27858551 (opens in a new tab).
- Daubert D, Pozhitkov A, McLean J, Kotsakis G. Titanium as a modifier of the peri-implant microbiome structure. Clin Implant Dent Relat Res. 2018;20(6):945-953. doi:10.1111/cid.12676 (opens in a new tab) PMID: 30255621 (opens in a new tab).
- Suárez-López Del Amo F, Garaicoa-Pazmiño C, Fretwurst T, Castilho RM, Squarize CH. Dental implants-associated release of titanium particles: A systematic review. Clin Oral Implants Res. 2018;29(11):1085-1100. doi:10.1111/clr.13372 (opens in a new tab) PMID: 30280418 (opens in a new tab).
- Pettersson M, Kelk P, Belibasakis GN, Bylund D, Molin Thorén M, Johansson A. Titanium ions form particles that activate and execute interleukin-1β release from lipopolysaccharide-primed macrophages. J Periodontal Res. 2017;52(1):21-32. doi:10.1111/jre.12364 (opens in a new tab) PMID: 26987886 (opens in a new tab).
- Fretwurst T, Nelson K, Tarnow DP, Wang HL, Giannobile WV. Is Metal Particle Release Associated with Peri-implant Bone Destruction? An Emerging Concept. J Dent Res. 2018;97(3):259-265. doi:10.1177/0022034517740560 (opens in a new tab) PMID: 29130804 (opens in a new tab).
- Mombelli A, Hashim D, Cionca N. What is the impact of titanium particles and biocorrosion on implant survival and complications? A critical review. Clin Oral Implants Res. 2018;29 Suppl 18:37-53. doi:10.1111/clr.13305 (opens in a new tab) PMID: 30306693 (opens in a new tab).
- Albrektsson T, Dahlin C, Jemt T, Sennerby L, Turri A, Wennerberg A. Is marginal bone loss around oral implants the result of a provoked foreign body reaction? Clin Implant Dent Relat Res. 2014;16(2):155-65. doi:10.1111/cid.12142 (opens in a new tab) PMID: 24004092 (opens in a new tab).
- Schwarz F, Derks J, Monje A, Wang HL. Peri-implantitis. J Periodontol. 2018;89 Suppl 1:S267-S290. doi:10.1002/JPER.16-0350 (opens in a new tab) PMID: 29926957 (opens in a new tab).
- Isidor F. Loss of osseointegration caused by occlusal load of oral implants. A clinical and radiographic study in monkeys. Clin Oral Implants Res. 1996;7(2):143-52. doi:10.1034/j.1600-0501.1996.070208.x (opens in a new tab) PMID: 9002833 (opens in a new tab).
- Heitz-Mayfield LJ, Schmid B, Weigel C, Gerber S, Bosshardt DD, Jönsson J, et al. Does excessive occlusal load affect osseointegration? An experimental study in the dog. Clin Oral Implants Res. 2004;15(3):259-68. doi:10.1111/j.1600-0501.2004.01019.x (opens in a new tab) PMID: 15142087 (opens in a new tab).
- Kozlovsky A, Tal H, Laufer BZ, Leshem R, Rohrer MD, Weinreb M, et al. Impact of implant overloading on the peri-implant bone in inflamed and non-inflamed peri-implant mucosa. Clin Oral Implants Res. 2007;18(5):601-10. doi:10.1111/j.1600-0501.2007.01374.x (opens in a new tab) PMID: 17655715 (opens in a new tab).
- Naert I, Duyck J, Vandamme K. Occlusal overload and bone/implant loss. Clin Oral Implants Res. 2012;23 Suppl 6:95-107. doi:10.1111/j.1600-0501.2012.02550.x (opens in a new tab) PMID: 23062133 (opens in a new tab).
- Katafuchi M, Weinstein BF, Leroux BG, Chen YW, Daubert DM. Restoration contour is a risk indicator for peri-implantitis: A cross-sectional radiographic analysis. J Clin Periodontol. 2018;45(2):225-232. doi:10.1111/jcpe.12829 (opens in a new tab) PMID: 28985447 (opens in a new tab).
- Wilson TG Jr. The positive relationship between excess cement and peri-implant disease: a prospective clinical endoscopic study. J Periodontol. 2009;80(9):1388-92. doi:10.1902/jop.2009.090115 (opens in a new tab) PMID: 19722787 (opens in a new tab).
- Dreyer H, Grischke J, Tiede C, Eberhard J, Schweitzer A, Toikkanen SE, et al. Epidemiology and risk factors of peri-implantitis: A systematic review. J Periodontal Res. 2018;53(5):657-681. doi:10.1111/jre.12562 (opens in a new tab) PMID: 29882313 (opens in a new tab).
- Monje A, Catena A, Borgnakke WS. Association between diabetes mellitus/hyperglycaemia and peri-implant diseases: Systematic review and meta-analysis. J Clin Periodontol. 2017;44(6):636-648. doi:10.1111/jcpe.12724 (opens in a new tab) PMID: 28346753 (opens in a new tab).
- Ramseier CA, Eick S, Brönnimann C, Buser D, Brägger U, Salvi GE. Host-derived biomarkers at teeth and implants in partially edentulous patients. A 10-year retrospective study. Clin Oral Implants Res. 2016;27(2):211-7. doi:10.1111/clr.12566 (opens in a new tab) PMID: 25682848 (opens in a new tab).
- Alassy H, Parachuru P, Wolff L. Peri-Implantitis Diagnosis and Prognosis Using Biomarkers in Peri-Implant Crevicular Fluid: A Narrative Review. Diagnostics (Basel). 2019;9(4). doi:10.3390/diagnostics9040214 (opens in a new tab) PMID: 31817894 (opens in a new tab).
- Berglundh T. Peri-Implant Diseases: The Past, the Present, the Future. J Periodontal Res. 2025;60(11):1059-1066. doi:10.1111/jre.70061 (opens in a new tab) PMID: 41431250 (opens in a new tab).
- Derks J, Ichioka Y, Dionigi C, Trullenque-Eriksson A, Berglundh J, Tomasi C, et al. Prevention and management of peri-implant mucositis and peri-implantitis: A systematic review of outcome measures used in clinical studies in the last 10 years. Clin Oral Implants Res. 2023;34 Suppl 25:55-67. doi:10.1111/clr.13925 (opens in a new tab) PMID: 35343614 (opens in a new tab).
- von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-7. doi:10.1016/S0140-6736(07)61602-X (opens in a new tab) PMID: 18064739 (opens in a new tab).
- Reference verification note. 49 of 49 references are PubMed-indexed; their bibliographic records (authors, title, journal, year, volume, pages, DOI, PMID) were retrieved programmatically from the PubMed database on November 17, 2026. Database retrieval confirms that each record exists as cited; it does not replace full-text reading by the responsible authors of every statement attributed to a source.

